Skip to content

ESTABLISHING THE DIAGNOSTIC AND PROGNOSTIC ROLE OF NARROW BAND IMAGING IN HEAD AND NECK CANCER

ESTABLISHING THE DIAGNOSTIC AND PROGNOSTIC ROLE OF NARROW BAND IMAGING IN HEAD AND NECK CANCER - NBI in HNC

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON47793
Enrollment
450
Registered
2015-08-20
Start date
2015-09-10
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck cancer HNSCC

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - suspicion of or proven carcinoma of the oral cavity, nasal cavity, pharynx or larynx. - suspicion of a benign lesion of the larynx - > 18 yrs of age - informed consent

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Primary Objective: to validate NBI (using flexible and rigid laryngosopes) in HNC as a prognosticator and establish NBI as a reliable diagnostic tool by discriminating (pre)malignant lesions from benign lesions

Secondary

MeasureTime frame
1. To identify NBI + WLI as superior to WLI alone in the early detection of local HNC recurrences after first line treatment 2. To identify NBI + WLI as a better diagnostic and staging tool in the determination of tumor field and as a consquence tumor staging than WLI alone 3. To conclude that inter-observer and intra-observer variability/reliability in the visual analysis of benign and (pre) malignant lesions in the upper aerodigestive tract is higher using NBI+WLI than WLI alone. 4. To increase reliability and decrease inter-/intra-observer variability by creating a NBI-atlas which will be helpful in correct interpretation of NBI.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)